Inhibitory action of the phosphatase inhibitor cantharidin on the endothelin-1-induced and the carbachol-induced negative inotropic effect in the canine ventricular myocardium.
In the canine ventricular myocardium, endothelin-1 and the muscarinic agonist carbachol scarcely affect the basal force of contraction but do induce a pronounced negative inotropic effect in the presence of beta-adrenoceptor agonists. Experiments were performed to examine whether the protein phosphatase inhibitor cantharidin inhibits the negative inotropic effect induced by endothelin-1 and carbachol in isolated canine ventricular trabeculae. In the presence of 100 nM norepinephrine, endothelin-1 (10 nM) and carbachol (30 nM) decreased the norepinephrine-induced positive inotropic effect to about 40% of the norepinephrine-induced maximal response. Cantharidin at 10 microM affected neither the basal force of contraction nor the positive inotropic effect of 100 nM norepinephrine, but it did attenuate markedly the negative inotropic effect of endothelin-1. By contrast, the negative inotropic effect of carbachol was not affected by 10 microM cantharidin. At 30 microM, cantharidin induced a positive inotropic effect and enhanced the positive inotropic effect of norepinephrine by approximately 60%. Cantharidin (30 microM) markedly attenuated the negative inotropic effect of 30 nM carbachol and partially decreased the negative inotropic effect of 100 nM carbachol. The present results indicate that the activation of phosphatase that is susceptible to cantharidin is involved in both the endothelin-1-induced and the carbachol-induced negative inotropic effect. The observation that the negative inotropic effect of endothelin-1 is inhibited by cantharidin at 10 microM and that cantharidin does not affect the negative inotropic effect of carbachol supports the view that the extent of the contribution of phosphatase activation may be higher in the endothelin-1-induced negative inotropic effect than in the carbachol-induced negative inotropic effect.